Physician profile
Timothy Friedrich
NPI 1649434036
$8,638.46
in general payments reported to CMS, 2019-2025
22 companies · $4,072 in 2025
The $4,072 reported for 2025 was more than what 92% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $908 · 2020: $558 · 2021: $1,472 · 2022: $469 · 2023: $869 · 2024: $290 · 2025: $4,072.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,430 · Food and Beverage: $1,495 · Travel and Lodging: $306.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,430.00 |
| Food and Beverage | $1,494.95 |
| Travel and Lodging | $305.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $4,395.22 | 2019-2025 | |
| Medwest Associates | $1,212.89 | 2021 | |
| Stryker Corporation | $903.91 | 2019-2025 | Infinity, Ortholoc 3di, T2 |
| Depuy Synthes Sales INC. | $690.70 | 2019-2025 | Hammerlock, Motoband, Dynaforce |
| Life Spine, INC. | $368.87 | 2020 | |
| Organogenesis INC. | $351.43 | 2021-2023 | Puraply |
| Wright Medical Technology, INC. | $132.21 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $129.54 | 2024-2025 | Euflexxa |
| Smith+Nephew, INC. | $112.93 | 2019-2025 | Grafix Pl, Collagenase Santyl, Regranex |
| Misonix INC | $60.20 | 2020 | |
| Paratek Pharmaceuticals, INC. | $55.31 | 2024 | Nuzyra |
| Melinta Therapeutics, LLC | $54.10 | 2019-2025 | Orbactiv, Kimyrsa |
| Lifenet Health | $38.31 | 2025 | Theragenesis Wound Matrix |
| Si-Bone, INC. | $22.93 | 2023 | |
| Hartmann USA, INC. | $18.33 | 2023 | Zetuvit Plus |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Next Science LLC | $17.83 | 2024 | Surgx, Xperience, Blastx |
| Avita Medical Americas, LLC | $16.22 | 2024 | |
| Pacira Therapeutics, INC. | $13.98 | 2019 | |
| Kci USA, INC. | $13.71 | 2023 | Activ.A.C., Promogran Prisma, Tegaderm |
| Horizon Therapeutics Plc | $12.08 | 2019 | |
| Orthofix Medical, INC. | $9.07 | 2025 | Physio-Stim |
| Kerecis Limited | $8.69 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Friedrich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.